Cytoplasmic retention of the DNA/RNA-binding protein FUS ameliorates organ fibrosis in mice
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci175158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Manuel Chiusa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology and Hypertension, and. Hauptthemen laut MEDLINE: RNA, Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, BLRD VA, NIA NIH HHS.
Abstract (Originalsprache)
Uncontrolled accumulation of extracellular matrix leads to tissue fibrosis and loss of organ function. We previously demonstrated in vitro that the DNA/RNA-binding protein fused in sarcoma (FUS) promotes fibrotic responses by translocating to the nucleus, where it initiates collagen gene transcription. However, it is still not known whether FUS is profibrotic in vivo and whether preventing its nuclear translocation might inhibit development of fibrosis following injury. We now demonstrate that levels of nuclear FUS are significantly increased in mouse models of kidney and liver fibrosis. To evaluate the direct role of FUS nuclear translocation in fibrosis, we used mice that carry a mutation in the FUS nuclear localization sequence (FUSR521G) and the cell-penetrating peptide CP-FUS-NLS that we previously showed inhibits FUS nuclear translocation in vitro. We provide evidence that FUSR521G mice or CP-FUS-NLS–treated mice showed reduced nuclear FUS and fibrosis following injury. Finally, differential gene expression analysis and immunohistochemistry of tissues from individuals with focal segmental glomerulosclerosis or nonalcoholic steatohepatitis revealed significant upregulation of FUS and/or collagen genes and FUS protein nuclear localization in diseased organs. These results demonstrate that injury-induced nuclear translocation of FUS contributes to fibrosis and highlight CP-FUS-NLS as a promising therapeutic option for organ fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Nephrology and Hypertension, and.
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Veterans Affairs, Nashville, Tennessee, USA.
- Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, Maine, USA.
- Department of Neuroscience, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Förderung
- NIDDK NIH HHS
- BLRD VA
- NIA NIH HHS
Zitieren
APA
Chiusa, M., Lee, Y. A., Zhang, M. Z., Harris, R. C., Sherrill, T., Lindner, V., Brooks, C. R., Yu, G., Fogo, A. B., Flynn, C. R., Zienkiewicz, J., Hawiger, J., Zent, R., & Pozzi, A. (2024). Cytoplasmic retention of the DNA/RNA-binding protein FUS ameliorates organ fibrosis in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci175158
Vancouver
Chiusa M, Lee YA, Zhang MZ, Harris RC, Sherrill T, Lindner V, et al. Cytoplasmic retention of the DNA/RNA-binding protein FUS ameliorates organ fibrosis in mice. Journal of Clinical Investigation. 2024. doi:10.1172/jci175158
BibTeX
@article{Chiusa2024,
author = {Chiusa, Manuel and Lee, Youngmin A and Zhang, Ming-Zhi and Harris, Raymond C and Sherrill, Taylor and Lindner, Volkhard and Brooks, Craig R and Yu, Gang and Fogo, Agnes B and Flynn, Charles R and Zienkiewicz, Jozef and Hawiger, Jacek and Zent, Roy and Pozzi, Ambra},
title = {Cytoplasmic retention of the DNA/RNA-binding protein FUS ameliorates organ fibrosis in mice},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci175158}
}
EUVIMED